{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:26:58Z","timestamp":1787840818048,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Human papillomavirus (HPV) is a known risk factor for cervical cancer, and currently, primary HPV typing is recommended for screening instead of cervical cytology. However, there are limited studies on the prevalence of HPV in Iran.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This cross-sectional study evaluated the liquid-based cervical smears of 700 women with no history of HPV vaccination and cervical dysplastic disease from 2017 to 2020 in Isfahan, Iran. Here, we compare the prevalence of HPV genotypes using COBAS with Pap smear cytology results in evaluating the most appropriate cervical cancer screening test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The prevalence of HPV infection was 23.3%, including 8.7% with HPV 16\/18 and 14.6% with other HR (high-risk) HPVs. In cytology reports, 8 out of 16 individuals with high-risk lesions were negative for any type of HPV; on the other hand, there were 129 HR HPV-positive patients out of 570 negative or low-risk Pap smear results.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>It assumed that there is no superiority for HPV genotyping over cytology or vice versa in detecting high-risk patients for cervical cancer; as only 26.8% of women with HPV show abnormal cytology; and from those with normal cytology, 17.9% were positive for HR HPV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijpvm.ijpvm_283_23","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:00:34Z","timestamp":1745496034000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Fundamental Place of Pap Test in Iran, Does Primary HPV-Genotyping Seem Cost-Effective in Replace? A Cohort Study"],"prefix":"10.4103","volume":"16","author":[{"given":"Azam","family":"Zafarbakhsh","sequence":"first","affiliation":[{"name":"Department of Urogynecology, Obstetrics and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fariba","family":"Behnamfar","sequence":"additional","affiliation":[{"name":"Department of Gynecology Oncology, Obstetrics, and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Reproductive Sciences and Sexual Health Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matin","family":"Shariati","sequence":"additional","affiliation":[{"name":"Department of Pathology, Isfahan University of Medical Sciences, Isfahan, Iran"},{"name":"Division of Population Health and Applied Health Sciences, Faculty of Medicine, Memorial University of Newfoundland, St. John \u2019s, NL, CA1B,3V6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atefeh","family":"Vaezi","sequence":"additional","affiliation":[{"name":"Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila Mousavi","family":"Seresht","sequence":"additional","affiliation":[{"name":"Department of Gynecology Oncology, Obstetrics, and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4]]},"reference":[{"key":"R1-20250825","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018:GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2019","journal-title":"Int J Cancer"},{"key":"R2-20250825","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/annonc\/mdn642","article-title":"Cancer incidence and mortality in Iran","volume":"20","author":"Mousavi","year":"2009","journal-title":"Ann Oncol"},{"key":"R3-20250825","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7314\/APJCP.2016.17.1.239","article-title":"Cervical cancer screening:Recommendations for muslim societies","volume":"17","author":"Khodakarami","year":"2016","journal-title":"Asian Pacific J Cancer Prev"},{"key":"R4-20250825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2023.1132369","article-title":"Epidemiology and survival of cervical cancer in Iran based on national cancer registry data (2008-2014)","volume":"13","author":"Akbari","year":"2023","journal-title":"Front Oncol"},{"key":"R5-20250825","first-page":"357","article-title":"Cervical cancer screening in Iranian women:Healthcare practitioner perceptions and views","volume":"18","author":"Refaei","year":"2017","journal-title":"Asian Pacific J Cancer Prev"},{"key":"R6-20250825","doi-asserted-by":"crossref","first-page":"343","DOI":"10.34172\/aim.2022.56","article-title":"Cost-Effectiveness of HPV vaccination;Need for Economic and Social Policy Intervention","volume":"25","author":"Fakhrolmobasheri","year":"2022","journal-title":"Arch Iran Med"},{"key":"R7-20250825","first-page":"111","article-title":"Gynecologic Cancers Estimates in the I. R. Iran, 2012- 2040","volume":"13","author":"Rostami","year":"2022","journal-title":"Basic Clin Cancer Res"},{"key":"R8-20250825","doi-asserted-by":"crossref","first-page":"12870","DOI":"10.1002\/jcb.28557","article-title":"The interaction of high and low-risk human papillomavirus genotypes increases the risk of developing genital warts:A population-based cohort study","volume":"120","author":"Hasanzadeh","year":"2019","journal-title":"J Cell Biochem"},{"key":"R9-20250825","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/OLQ.0000000000000193","article-title":"The estimated lifetime probability of acquiring human papillomavirus in the United States","volume":"41","author":"Chesson","year":"2014","journal-title":"Sex Transm Dis"},{"key":"R11-20250825","first-page":"1","article-title":"Cancer control in low-and middle-income countries:Is it time to consider screening?J Glob Oncol","volume":"5","author":"Shah","year":"2019"},{"key":"R12-20250825","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.vhri.2018.03.001","article-title":"Cost-effectiveness analysis of the introduction of HPV vaccination of 9-year-old-girls in Iran","volume":"15","author":"Yaghoubi","year":"2018","journal-title":"Value Heal Reg Issues"},{"key":"R13-20250825","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S1473-3099(20)30860-4","article-title":"Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources:A mathematical modelling analysis","volume":"21","author":"Drolet","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"R14-20250825","article-title":"The most common cancers in Iranian women","volume":"38","author":"Emami","year":"2009","journal-title":"Iran J Publ Health"},{"key":"R16-20250825","first-page":"77","article-title":"An epidemiological review of common cancers in Iran;A review article","volume":"11","author":"Danaei","year":"2019","journal-title":"Iran J Blood Cancer"},{"key":"R17-20250825","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J Low Genit Tract Dis"},{"key":"R18-20250825","doi-asserted-by":"crossref","first-page":"156","DOI":"10.12788\/jcso.0039","article-title":"Cobas HPV test for first-line screening for cervical cancer","volume":"12","author":"Stenger","year":"2014","journal-title":"J Community Support Oncol"},{"key":"R19-20250825","doi-asserted-by":"crossref","first-page":"46. e1","DOI":"10.1016\/j.ajog.2011.07.024","article-title":"The ATHENA human papillomavirus study:Design, methods, and baseline results","volume":"206","author":"Wright","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20250825","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/dc.23959","article-title":"High grade squamous intraepithelial lesion on high-risk HPV negative patients:Why we still need the Pap test","volume":"46","author":"Sun","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"R21-20250825","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2020.01.023","article-title":"The risk of cervical cancer after cervical intraepithelial neoplasia grade 3:A population-based cohort study with 80,442 women","volume":"157","author":"Loopik","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R22-20250825","first-page":"516","article-title":"HPV genotype distribution among women with normal and abnormal cervical cytology in Turkey","volume":"32","author":"Muderris","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"R23-20250825","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/jmv.25477","article-title":"Prevalence and genotype distribution of human papillomavirus infection among women:A population-based study in Dali Bai Autonomous Prefecture, Yunnan Province, China","volume":"91","author":"Su","year":"2019","journal-title":"J Med Virol"},{"key":"R24-20250825","first-page":"e0249134","article-title":"The prevalence of 30 HPV genotypes detected by EUROArray HPV in cervical samples among unvaccinated women from Vojvodina province, Serbia PLoS One","volume":"16","author":"Kovacevic","year":"2021"},{"key":"R25-20250825","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4081\/jphr.2014.157","article-title":"Prevalence and molecular epidemiology of human papillomavirus infection in italian women with cervical cytological abnormalities","volume":"3","author":"Meloni","year":"2014","journal-title":"J Public health Res"},{"key":"R26-20250825","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1742-6413.67112","article-title":"Colposcopic evaluation of cervix with persistent inflammatory Pap smear:A prospective analytical study","volume":"7","author":"Dasari","year":"2010","journal-title":"Cytojournal"},{"key":"R27-20250825","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13027-018-0178-5","article-title":"Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing","volume":"13","author":"Jamdar","year":"2018","journal-title":"Infect Agent Cancer"},{"key":"R28-20250825","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1750-9378-8-20","article-title":"Prevalence and type distribution of high-risk human papillomavirus in patients with cervical cancer:A population-based study","volume":"8","author":"Haghshenas","year":"2013","journal-title":"Infect Agent Cancer"},{"key":"R29-20250825","first-page":"3373","article-title":"Human papilloma virus genotype distribution in cervical lesions in Zanjan, Iran","volume":"18","author":"Ahmadi","year":"2017","journal-title":"Asian Pacific J Cancer Prev APJCP"},{"key":"R30-20250825","first-page":"1159","article-title":"Distribution of human Papillomavirus genotypes in liquid-based samples;abundance of HPV-53 in Tehran, Iran","volume":"43","author":"Pouryasin","year":"2014","journal-title":"Iran J Public Health"}],"container-title":["International Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.ijpvm_283_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:29:31Z","timestamp":1787837371000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijpvm.ijpvm_283_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":28,"URL":"https:\/\/doi.org\/10.4103\/ijpvm.ijpvm_283_23","relation":{},"ISSN":["2008-7802","2008-8213"],"issn-type":[{"value":"2008-7802","type":"print"},{"value":"2008-8213","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"2023-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}